QA: Myovant Sciences Ltd. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001679082_2019_Myovant_Sciences_Ltd.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001679082')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001679082, Myovant Sciences Ltd.

  xvar xval
0 AssetsCurrent 114,763,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,273,000
3 remainder_Assets 3,065,000
4 LiabilitiesCurrent 37,085,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 44,287,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,231,000
9 ResearchAndDevelopmentExpense 116,832,000
10 remainder_Expenses 2,259,000
11 remainder_Revenues 0
12 remainder_NetIncome 67,000
13 remainder_ComprehensiveNetIncome -116,000
  yvar yval
0 Assets 119,101,000
1 Liabilities 81,372,000
2 Expenses 143,322,000
3 Revenues 0
4 StockholdersEquity 37,729,000
5 NetIncome -143,255,000
6 ComprehensiveNetIncome -143,313,000
7 BaseVar 171,989,000
8 EconomicCapitalRatio -0.782

Edgar->Model Mapping

Feature Distribution

Change over Time